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Background: In 2015, new disability weights (DWs) for infectious diseases were constructed based on data from
four European countries. In this paper, we evaluated if country, age, sex, disease experience status, income and
educational levels have an impact on these DWs. Methods: We analyzed paired comparison responses of the
European DW study by participants’ characteristics with separate probit regression models. To evaluate the effect
of participants’ characteristics, we performed correlation analyses between countries and within country by
respondent characteristics and constructed seven probit regression models, including a null model and six
models containing participants’ characteristics. We compared these seven models using Akaike Information
Criterion (AIC). Results: According to AIC, the probit model including country as covariate was the best model.
We found a lower correlation of the probit coefficients between countries and income levels (range rs: 0.97–0.99,
P<0.01) than between age groups (range rs: 0.98–0.99, P<0.01), educational level (range rs: 0.98–0.99, P<0.01),
sex (rs = 0.99, P<0.01) and disease status (rs = 0.99, P<0.01). Within country the lowest correlations of the probit
coefficients were between low and high income level (range rs = 0.89–0.94, P<0.01). Conclusions: We observed
variations in health valuation across countries and within country between income levels. These observations
should be further explored in a systematic way, also in non-European countries. We recommend future
researches studying the effect of other characteristics of respondents on health assessment.
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Introduction
The Global Burden of Disease (GBD) studies, which started in theearly 1990 s, presented an important set of comparative findings
on the impact of different diseases, injuries and risk factors on
population health.1,2 One of the most important results of these ini-
tiatives has been the introduction of the disability-adjusted life year
(DALY), a new measure of overall disease burden, reflecting the
number of healthy life years lost due to illness, disability or early
death. This metric accounts for both premature mortality, expressed
as years of life lost (YLLs) and time spent in states of reduced health,
expressed as years lived with disability (YLDs). An essential parameter
to calculate YLDs is the disability weight (DW), representing the
severity of health loss associated with illness or disability. The DW
is a value on a scale from zero to one: a DW of 0 means that a health
state is equivalent to full health, whereas a DW equal to 1 means that a
health state is equivalent to death. The value of a DW can be derived
from the valuations of a panel of judges stated toward a set of
hypothetical health states expressing the relative undesirability of
the health state.3,4 There are three main types of health state
valuation methods: (1) trade-off methods such as the time trade-
off, and the person trade-off; (2) discrete choice experiments and
(3) scales such as the Rating or Visual Analogue Scale or a combin-
ation of these.5
In 2012, an update of the GBD study was performed, including a
new set of DWs for 220 unique health states.6 To assess the DWs, the
GBD 2010 study proposed a new ordinal health state valuation
methodology based on paired comparisons questions, a type of
discrete choice question and a new population health equivalence
technique, a type of trade-off method, to anchor DWs to the scale
(from zero to one) aiming to address criticisms of previous
approaches.7–9 With paired comparisons two descriptions of hypo-
thetical health states are presented to respondents who have to
decide which they regard as being healthier.
In 2008, the European Centre for Disease Prevention and Control
(ECDC) launched an initiative to estimate the current and future
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burden of communicable disease in the European Union (EU) and
European Economic Area (EEA) countries using DALYs.10,11
For the purpose of estimating the burden of communicable disease
in Europe, the DWs developed for the GBD 2010 study6 had a number
of limitations. The set of DWs was derived from a household survey
based on responses from the general population of five non-European
countries and from an open-access web-survey study performed in 167
countries with most of the participants from North America and
Australia. This web-survey study was available in English, Spanish
and Mandarin, whereas German (16%) is the most spoken language
in Europe.12 Consequently the DWs were not based on the values
representative of socio-demographic groups of the EU/EEA popula-
tion.13 Moreover, DWs for 74 health states related to infectious
diseases did not exist at all. Therefore ECDC, the Institute for Health
Metrics and Evaluation and others started a collaboration to assess new
DWs. They performed a web-based survey in Hungary, the
Netherlands, Sweden and Italy14 because these four countries were
considered geographically representative of the EU/EEA Member States.
The results of this study showed a high degree of agreement
between the GBD 2010 and the European study. However, the
putative differences in DWs between respondent characteristics with
respect to their ranking of infectious diseases were not assessed.
Previous studies already demonstrated that respondent characteristics
such as age,15,16 income level,17 country,18,19 health status20 or pro-
fession21 may have an impact on health evaluation, and consequently
on derived utility or DW. However, none of these previous studies
specifically looked into the implications for DWs derived from
pairwise comparisons. If significant differences in health valuation
would exist in the derivation of infectious disease DWs, these may
have to be taken into account in the selection of study populations of
future studies aiming to assess infectious disease DWs or in the trans-
lation of study results to the general population.
The objective of the current study is therefore to compare DWs
between the four European countries and across respondents’
characteristics.
Methods
Study design and participants
We performed a web-based survey between September and
November 2013 in Hungary, the Netherlands, Sweden and Italy.14
The eligible study population was aged from 18 to 65 years. The
participants were recruited through existing large panels of people
available through the Growth From Knowledge (GFK) Company for
participating in online surveys.
Outcome trees
In addition to acute illnesses, infections can also lead to long-term
consequences. To estimate the full burden caused by an infection, all
health outcomes caused by the infection have to be estimated.10,22
This process, which relates all outcomes to their infectious causes
results in an ‘outcome tree’ or a ‘disease model’,23 representing all
health outcomes that are causally related to a hazard, their possible
transition and transition probabilities in a flow chart.24 In total, 32
infectious diseases and six healthcare-associated infections were
included in the burden of communicable disease in Europe study.
These 32 infectious diseases and six healthcare-associated infections
had 74 unique health states for which DWs were evaluated in this
study.24
The short health state descriptions (35 words or fewer) were
developed by Salomon et al. to emphasize the major functional con-
sequences and symptoms associated with each health state with
simple non-clinical vocabulary. The health state descriptions used
in this study are available from Ref. 14.
Procedures
We adapted the questionnaire developed by Salomon et al.6 by
including additional questions about disease experience and by
changing income and educational categories to fit the situation in
the four countries. For disease experience status we asked if the
participant suffered from a disease or the consequences of an
injury. We used existing health state descriptions developed by
Salomon et al.6 for 74 health states related to infectious diseases.
Three different versions of the questionnaire were designed. Each
version included questions about demographics of the participant
(age, sex, educational and income level and disease experience), and
each participant received only one version of the questionnaire. The
first version was composed of 15 pairwise comparison (PWC)
questions on chronic (life-long health) states and three population
equivalence questions (PHE). The second version of the question-
naire included 15 paired comparison questions on temporary
(lasting 1 week) health states and three PHE questions. The third
version included five PWC questions with a chronic framing to
accommodate PHE questions questions and three PHE questions.
PHE questions, which allow to anchor the final DWs from 0 to 1 and
to elicit trade-offs between mortality and nonfatal health states, were
finally not used in the European DW study. For the PWC questions,
participants were asked to imagine that two people have the same
number of years left to live, and that they will experience the health
problems described for the rest of their lives (or for 1 week for
temporary health state). Then, the respondents were presented
with two descriptions of hypothetical people, each living in a
particular health state, and then asked which person they regarded
as being healthier.
For instance:
 ‘The first person has diarrhea three or more times a day with
occasional discomfort in the belly’.
 ‘The second person has a low fever and mild discomfort, but no
difficulty with daily activities.’
Who do you think is healthier overall, the first person or the second
person?’
The questionnaires and health states were translated from English to
Hungarian, Dutch, Swedish and Italian and then checked by an in-
dependent native speaker.
The questionnaire was assigned to participants through a
computer algorithm that first attributed the study version with the
lowest percentage of participants at the time of assignment. Then
after the version was allocated, the algorithm selected the health
states to include in the questionnaire based on the minimum
number of allocations that the health state had at that moment.
Statistical analysis
To assess the representativeness of our study population, we applied
chi-squared tests to assess the comparability of the age, sex and
educational distribution of the study population with those of the
respective national populations. Because income levels were
categorized, we assigned the midpoint of each income category to
all respondents in that category, which we compared with mean
household income values from Eurostat.25
To investigate the differences between health states, we ran probit
regression analyses on the choice responses. The first health state of
the pair had a value of 1, the second health state of the pair had a
value of –1 and those not in the pair had a value of 0. The resulting
probit regression coefficients for each health state expressed the
relative differences in valuation of the health state on an arbitrary
scale. To project the results from the probit regression model on a
DW scale ranging from zero to one, we ran a locally weighted
scatterplot smoothing regression model (loess) of the probit
regression coefficients vs. the logit transformed GBD2010 DWs.14
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We then predicted logit transformed DWs for each of the probit
coefficients from the loess fit. To change the scale and obtain values
ranging between 0 and 1 we applied an inverse logistic transform-
ation of these predicted DWs. We estimated uncertainty around the
mean DWs through a bootstrap procedure. We first generated 200
samples of the pairwise coefficients using their probit estimated
mean and standard deviation. We then used the generated samples
to calculate 200 loess fits. We generated 200 samples for each of the
DWs using loess fit, producing 40 000 bootstrap samples for each
DW. We finally calculated uncertainty intervals (UI) as the 2.5th and
97.5th percentile of the corresponding distribution of bootstrapped
samples intervals for the DW. These analyses were performed using
the overall database of 255 health states available in Haagsma et al.14
We hereby extracted the 74 probit coefficients and DWs of the
health states relating to infectious diseases, which were the
primary focus of this study.
We performed the same analysis of the responses across countries,
sex, age, disease experience status, income and education level and
within countries by sex, age, disease experience status, income and
education level.
The Spearman correlation coefficient was also used to evaluate the
relation of both the probit coefficients between countries, age
groups, sex, disease experience status, educational and income level.
To evaluate the effect of participants’ characteristics, we also
estimated difference between two health states in models with inter-
actions that allow each country, or each population subgroups to
have its own set of distinct values, assuming that the difference
between the two state values was normally distributed. We then
compared models using Akaike’s Information Criterion (AIC).
We interpreted a P value < 0.05 as significant. Analyses were done
with R (version 3.0.2) and using the speedglm package.26
Results
Characteristics of respondents
Overall, 30 660 respondents completed the DW survey of which 6053
participants (20%) were from Hungary, 8054 (26%) from Italy, 8005
(26%) from the Netherlands and 8548 (28%) from Sweden.
The average age was 41.5 years (standard deviation [sd] 13.3) in
Hungary, 41.7 years in Italy (sd 12.3), 44.1 years in the Netherlands
(sd 12.9) and 41.9 years in Sweden (sd 13.7). Approximately half of
the respondents were male in each of the four countries.
The majority of the respondents had a medium educational level
in Hungary (49%), Italy (48%) and Sweden (51%) but while in the
Netherlands the level of education of the participants was more
equally distributed (low: 35%, medium: 35% and high: 30%).
Most of the respondents had a low income level in Italy (47%),
medium income level in the Netherlands (56%) and Sweden (50%)
and high income level in Hungary (47%) (table 1).
Approximately one in three respondents reported that they were
suffering of a disease or of the consequences of an injury in Hungary
(34%), the Netherlands (29%) and Sweden (35%) and one in five
respondents in Italy (18%) (table 1).
Comparison of the study population with data from Eurostat
showed that the study population was representative of the
national populations in the four countries in terms of sex distribu-
tion, age distribution and educational levels.27 For income levels we
observed that, except in Sweden, mean income of the respondents
was higher than in the general population table 1.
Probit regression models
We observed that all models, except the model including disease
experience status (model 3) (AIC = 417 722), had lower AIC than
the model without covariate (AIC = 417 572). We also observed
that the model including country as covariate had the lowest AIC
(411 142), the next lowest being the based on age (AIC = 416 940),
then on educational level (AIC = 417 178), on sex (AIC = 417 271)
and finally on disease experience status (AIC = 417 722). That means
that probit model including country as covariate was the best model
because AIC represents the loss of information caused by using
models to represent the process generating the actual data. We did
not compare the AIC for the model including income level as
covariate with the other models because it included less data
because of the missing answers (table 2).
Probit regression coefficients–correlation coefficients
Between country
All correlation coefficients were significantly different from zero
(P < 0.001).
Overall, we found a lower correlation of the probit coefficients
between country than between age-groups, educational, income, sex
and disease experience status (figure 1). The highest linear correl-
ation of the probit coefficients was found between Italy and Hungary
(rs = 0.95) and the lowest correlation was observed between Hungary
and the Netherlands (rs = 0.89) (figure 1).
The correlation of the probit coefficients was high between age
groups (range rs: 0.98–0.99), educational levels (range rs: 0.98–0.99),
sex (rs = 0.99) and disease experience status (rs = 0.99) and lower for
income levels (range rs: 0.97–0.99).
Within-country
All correlation coefficients were significantly different from zero
(P < 0.001).
We observed a higher correlation of the probit coefficients by age-
groups in the Netherlands (range rs: 0.97–0.98) than in Hungary
(range rs: 0.95–0.96), Italy (range rs: 0.95–0.97) or Sweden (range
rs: 0.96–0.97). In all countries, the highest correlation was observed
between 35–49 years and 50–65 years groups. In every country,
except for the Netherlands, the lowest observed correlation was
between 18–34 years and 50–64 years. In the Netherlands, the
lowest observed correlation was between 18–34 years and 35–
49 years groups (rs = 0.97).
We observed roughly the same pattern for educational levels. The
correlation of the coefficients was higher in the Netherlands (range
rs: 0.97–0.98) than in Hungary (range rs: 0.94–0.98), Italy (range
rs 0.94–0.96) and Sweden (range rs: 0.95–0.98). In every country,
except Sweden, the highest correlation was observed between low
and medium educational level. In Sweden the highest correlation
was observed between medium and high educational level
(rs = 0.98). Except for the Netherlands, the lowest observed correl-
ation was between low and high educational level. In the
Netherlands, the lowest observed correlation was between medium
and high educational groups (rs = 0.97).
We observed relatively less concordance of the responses between
income levels across country. The correlation of the coefficients was
better in Hungary (range rs: 0.94–0.95) than in the Netherlands
(range rs: 0.92–0.98), Italy (range rs: 0.89–0.95) and Sweden (range
rs: 0.93–0.98). The lowest correlation was observed between medium
and high income levels in the Netherlands (rs = 0.92) and between
low and high income levels in Hungary (rs = 0.94), Italy (rs = 0.89)
and Sweden (rs = 0.93). The highest correlation was observed
between low and medium income levels in the Netherlands
(r = 0.98) and Sweden (r = 0.98) and between medium and high
levels in Hungary (rs = 0.94) and Italy (rs = 0.93).
We observed a higher correlation of the coefficients between
disease experience status in Sweden (rs = 0.99) than in the
Netherlands (rs = 0.97), Hungary (rs = 0.97) and Italy (rs = 0.96).
In all countries, we observed a high correlation of the probit co-
efficients between sex (range rs: 0.97–0.98).
Overall, within country, we observed a lower correlation of the
coefficients by income levels than by age groups, educational levels,
sex and disease experience status.
126 European Journal of Public Health
Downloaded from https://academic.oup.com/eurpub/article-abstract/28/1/124/4111224
by Erasmus Universiteit Rotterdam user
on 19 February 2018
T
a
b
le
1
D
e
sc
ri
p
ti
o
n
o
f
th
e
st
u
d
y
p
o
p
u
la
ti
o
n
T
o
ta
l
H
u
n
g
a
ry
H
u
n
g
a
ri
a
n
p
o
p
u
la
ti
o
n
P
-v
a
lu
e
b
It
a
ly
It
a
li
a
n
p
o
p
u
la
ti
o
n
P
-v
a
lu
e
b
N
e
th
e
rl
a
n
d
s
D
u
tc
h
p
o
p
u
la
ti
o
n
P
-v
a
lu
e
b
S
w
e
d
e
n
S
w
e
d
is
h
p
o
p
u
la
ti
o
n
P
-v
a
lu
e
b
(n
=
3
0
6
6
0
)
(n
=
6
0
5
3
)
(%
)a
(n
=
8
0
5
4
)
(%
)a
(n
=
8
0
0
5
)
(%
)a
(n
=
8
5
4
8
)
(%
)a
S
e
x
M
e
n
1
4
7
1
9
2
8
8
9
4
7
.6
0
.9
9
9
3
8
8
6
4
8
.4
0
.9
9
9
3
8
4
2
4
9
.5
0
.9
4
3
4
1
0
2
4
9
.9
0
.9
0
2
(4
8
.0
%
)
(4
7
.7
%
)
(4
8
.2
%
)
(4
8
.0
%
)
(4
8
.0
%
)
A
g
e
0
.9
9
3
0
.9
8
2
0
.5
8
4
0
.8
6
9
1
8
–3
4
ye
a
rs
9
5
7
4
2
0
4
7
3
4
.1
2
5
2
2
3
0
.2
2
1
4
8
3
3
.3
2
8
5
7
3
6
.5
(3
1
.2
%
)
(3
3
.8
%
)
(3
1
.3
%
)
(2
6
.8
%
)
(3
3
.4
%
)
3
5
–4
9
ye
a
rs
1
0
7
5
3
2
0
2
6
3
4
2
9
8
3
3
8
.1
2
8
8
3
3
4
.3
2
8
6
1
3
3
.4
(3
5
.1
%
)
(3
3
.5
%
)
(3
7
.0
%
)
(3
6
.0
%
)
(3
3
.5
%
)
5
0
–6
5
ye
a
rs
1
0
3
3
3
1
9
8
0
3
1
.9
2
5
4
9
3
1
.7
2
9
7
4
3
2
.4
2
8
3
0
3
0
.1
(3
3
.7
%
)
(3
2
.7
%
)
(3
1
.6
%
)
(3
7
.2
%
)
(3
3
.1
%
)
E
d
u
ca
ti
o
n
a
l
le
v
e
l
0
.2
4
2
0
.4
9
0
.9
5
0
.5
4
6
Lo
w
9
1
2
5
2
3
4
4
8
0
.9
2
6
6
8
8
6
.1
2
8
0
1
7
1
.4
1
3
1
2
6
9
.9
(2
9
.8
%
)
(3
8
.7
%
)
(3
3
.1
%
)
(3
5
.0
%
)
(1
5
.3
%
)
M
e
d
iu
m
1
4
0
0
0
2
9
7
6
3
8
9
6
2
8
0
4
4
3
2
4
(4
5
.7
%
)
(4
9
.2
%
)
(4
8
.4
%
)
(3
5
.0
%
)
(5
0
.6
%
)
H
ig
h
7
5
3
5
7
3
3
1
9
.1
1
4
9
0
1
3
.9
2
4
0
0
2
8
.6
2
9
1
2
3
0
.1
(2
4
.6
%
)
(1
2
.1
%
)
(1
8
.5
%
)
(3
0
.0
%
)
(3
4
.1
%
)
In
co
m
e
le
v
e
l
(n
=
2
3
9
5
0
)
n
a
n
a
n
a
n
a
Lo
w
9
4
5
8
1
3
0
1
3
1
7
7
2
0
5
3
2
9
2
7
(3
9
.4
%
)
(3
0
.0
%
)
(4
7
.2
%
)
(3
5
.3
%
)
(4
1
.4
%
)
M
e
d
iu
m
1
0
8
7
9
1
0
1
6
3
0
8
3
3
2
7
1
3
5
0
9
(4
5
.4
%
)
(2
3
.4
%
)
(4
5
.8
%
)
(5
6
.3
%
)
(4
9
.7
%
)
H
ig
h
3
6
1
3
2
0
2
6
4
7
2
4
8
4
6
3
1
(1
5
.1
%
)
(4
6
.6
%
)
(7
.0
%
)
(8
.3
%
)
(8
.9
%
)
M
e
a
n
[S
D
]
(E
)
6
7
7
8
[3
2
7
6
]
5
4
6
9
2
5
7
6
4
[1
7
7
2
3
]
1
8
9
9
7
3
9
8
3
9
[2
3
8
5
0
]
2
3
8
0
2
2
3
4
0
4
[1
2
5
4
1
]
2
7
7
2
8
D
is
e
a
se
e
x
p
e
ri
e
n
ce
n
a
n
a
n
a
n
a
Y
e
s
8
9
0
0
2
0
8
5
N
A
1
4
4
8
2
3
3
7
(2
9
.2
%
)
N
A
3
0
2
6
N
A
(2
9
.0
%
)
(3
4
.4
%
)
(1
8
.0
%
)
(3
5
.4
%
)
a
:
A
cc
o
rd
in
g
to
E
u
ro
st
a
t:
h
tt
p
:/
/e
c.
e
u
ro
p
a
.e
u
/e
u
ro
st
a
t/
d
a
ta
/d
a
ta
b
a
se
(2
0
1
3
p
o
p
u
la
ti
o
n
).
b
:
P
va
lu
e
s
re
su
lt
in
g
fr
o
m
th
e
ch
i-
sq
u
a
re
te
st
.
N
A
:
N
o
t
A
va
il
a
b
le
.
n
a
:
n
o
t
a
p
p
li
ca
b
le
.
Disability weights for infectious diseases in four European countries 127
Downloaded from https://academic.oup.com/eurpub/article-abstract/28/1/124/4111224
by Erasmus Universiteit Rotterdam user
on 19 February 2018
Except for income level, Dutch participants showed higher
correlation of the probit coefficients for all participants’
characteristics.
Disability weights
‘Distance vision, mild impairment’ had the lowest DW in Hungary
[H]: 0.007 [95% UI 0.004–0.013], Italy [I]: 0.004 [95% UI 0.002–
0.008] and Sweden [S]: 0.005 [95% UI 0.003–0.009]). ‘Hearing loss,
mild’ had the lowest DW in Netherlands [N]: 0.004 [95% UI 0.002–
0.009]. ‘Intensive care unit admission’ had the highest DW for all the
countries (H: 0.597 [95% UI 0.464–0.690]; I: 0.530 [95% UI 0.430–
0.617]; N: 0.624 [95% UI 0.493–0.719] and S: 0.717 [95% UI 0.552–
0.766]) (table 3).
The median DW of all health states based on the responses of the
Hungarian respondents was 0.118 (range: 0.007–0.597), 0.101
(range: 0.004–0.530) in Italian respondents, 0.108 (range: 0.004–
0.624) in Dutch respondents and 0.111 (range: 0.005–0.717) in
Swedish respondents. The range of DWs was higher in Swedish par-
ticipants (0.712) and lower in Italian participants (0.526) but the
shape of the DW distributions were right-skewed in all countries
(Supplementary Appendix) and highly correlated (rs 0.99,
P < 0.01), including in the range below 0.2, where most of the
European DWs reside (rs 0.97, P < 0.01).
The differences of DWs ranged from –0.135 (‘Thrombocytopenic
purpura’) to 0.197 (‘Lymphogranuloma Venereum–local infection’)
between Hungary and Italy, from –0.221 (‘AIDS cases, not receiving
ARV treatment’) to 0.295 (‘Motor plus cognitive impairments,
severe’) between Hungary and the Netherlands and from –0.165
(‘Musculoskeletal problems, generalized, severe’) to 0.250
(‘Stoma’) between Hungary and Sweden. The differences of DWs
also ranked from –0.203 (‘End-stage renal disease, on dialysis’) to
0.226 (‘Motor plus cognitive impairments, severe’) between Italy
and the Netherlands, from –0.187 (‘Intensive care unit admission’)
to 0.241 (‘Stoma’) between Italy and Sweden and from –0.232
(‘Motor plus cognitive impairments, severe’) to 0.154
(‘Tuberculosis, not HIV infected’) between the Netherlands and
Sweden. The biggest observed differences of DW were for ‘motor
plus cognitive impairments, severe’ between Hungary and the
Netherlands, between the Netherlands and Sweden and between
Italy and the Netherlands (Hungary: 0.496; Italy: 0.426, The
Netherlands: 0.200, Sweden: 0.432) and for ‘Stoma’, between Italy
and Sweden and between Hungary and Sweden (Hungary: 0.301,
Italy: 0.292, Sweden: 0.051). There were no differences in DW
between Hungary and Netherlands for ‘Near Vision Impairment’,
for ‘Distance vision, mild impairment’ and ‘Infertility, primary’
between Netherlands and Italy, for ‘Unilateral hearing loss’
between Netherlands and Sweden, for ‘Hearing loss, mild’,
Table 2 AIC of seven probit models, including a null model and six
models containing one covariate, i.e. country, sex, age, disease
experience status, income level, or educational level
Probit models AIC
(1) Null model 417 572
(2) Country 411 142
(3) Disease experience status 417 722
(4) Sex 417 271
(5) Educational level 417 178
(6) Income level NAa
(7) Age 416 940
aNot available: AIC not calculated because it included less data than
the other models.
Figure 1 Correlation matrix of probit coefficients by country, educational level, sex, age, income level and disease experience status
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Table 3 Comparison of the rank order (descending) of the health states between countries
sdnalrehteNsetatshtlaeH  Hungary Italy Sweden 
Intensive care unit admission 1 1 1 1 
AIDS cases, not receiving ARV treatment 2 12 3 4 
Terminal phase, without medication (for cancers, end-stage 
kidney/liver disease) 
3 3 2 3 
End-stage renal disease, on dialysis 4 5 14 7 
Musculoskeletal problems, generalized, severe 5 11 8 2 
Terminal phase, with medication (for cancers, end-stage 
kidney/liver disease) 
6 7 5 6 
Subacute sclerosing panencephalitis – phase 3 7 2 4 5 
COPD and other chronic respiratory problems, severe 8 6 13 13 
Tuberculosis, HIV infected 9 13 9 16 
Musculoskeletal problems, generalized, moderate 10 22 15 12 
Tuberculosis, not HIV infected 11 18 16 21 
Encephalopathy - severe 12 8 10 11 
Encephalopathy - moderate 13 10 12 10 
Abdominopelvic problem, severe 14 15 24 15 
HIV cases, symptomatic, pre-AIDS 15 19 11 17 
Tuberculosis of vertebrae 16 20 20 18 
COPD and other chronic respiratory problems, moderate 17 14 19 22 
Motor impairment, severe 18 9 6 8 
Infectious disease, post-acute consequences (fatigue, emotional
lability, insomnia) 
19 31 28 25 
Crohn's disease or ulcerative colitis 20 29 30 24 
Epididymo-orchitis 21 27 29 38 
Diabetic neuropathy 22 32 37 26 
Infectious disease, acute episode, severe 23 41 47 33 
Diarrhea, severe 24 24 27 14 
Motor plus cognitive impairments, severe 25 4 7 9 
(Continued)
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Table 3 Continued
Subacute sclerosing panencephalitis – phase 2 26 16 18 19 
Decompensated cirrhosis of the liver 27 34 32 31 
Generic uncomplicated disease: anxiety about diagnosis 28 44 31 48 
Thrombocytopenic purpura 29 39 23 34 
HIV/AIDS cases, receiving ARV treatment 30 53 39 36 
Chronic kidney disease (stage IV) 31 40 46 40 
Diarrhea, moderate 32 36 41 23 
Musculoskeletal problems, upper limbs, moderate 33 37 44 32 
Distance vision blindness 34 26 26 29 
Musculoskeletal problems, lower limbs, severe 35 28 35 30 
Subacute sclerosing panencephalitis – phase 1 36 43 43 47 
Motor plus cognitive impairments, moderate 37 30 22 20 
Diarrhea, mild 38 55 54 41 
Distance vision, severe impairment 39 25 25 28 
Generic uncomplicated disease: worry and daily medication 40 50 38 53 
Invasive device/drain 41 21 21 43 
Abdominopelvic problem, moderate 42 33 33 27 
Musculoskeletal problems, lower limbs, moderate 43 35 40 46 
Stoma 44 17 17 51 
Infectious disease, acute episode, moderate 45 56 56 55 
Hearing loss, complete, with ringing 46 38 34 35 
Hearing loss, moderate, with ringing 47 45 51 45 
Hearing loss, profound, with ringing 48 42 36 39 
End-stage renal disease, with kidney transplant 49 71 57 63 
Lymphogranuloma Venereum - local infection 50 23 53 52 
Irritable bowel syndrome 51 47 59 37 
(Continued)
130 European Journal of Public Health
Downloaded from https://academic.oup.com/eurpub/article-abstract/28/1/124/4111224
by Erasmus Universiteit Rotterdam user
on 19 February 2018
Table 3 Continued
Hearing loss, mild, with ringing 52 54 58 50 
COPD and other chronic respiratory problems, mild 53 61 68 60 
Hearing loss, severe, with ringing 54 51 45 49 
Motor impairment, moderate 55 46 52 42 
Abdominopelvic problem, mild 56 69 65 64 
Conjunctivitis without corneal scar 57 63 69 68 
Hearing loss, profound 58 57 50 58 
Musculoskeletal problems, upper limbs, mild 59 48 42 54 
Distance vision, moderate impairment 60 49 55 62 
Motor plus cognitive impairments, mild 61 52 48 44 
Musculoskeletal problems, lower limbs, mild 62 60 60 56 
Ear pain 63 65 64 65 
Hearing loss, moderate 64 62 63 59 
Motor impairment, mild 65 64 72 66 
Hearing loss, severe 66 59 61 61 
Infertility, secondary 67 68 73 73 
Hearing loss, complete 68 58 49 57 
Infectious disease, acute episode, mild 69 73 67 70 
Near vision impairment 70 67 62 67 
Infertility, primary 71 66 70 71 
Unilateral hearing loss 72 70 66 69 
Distance vision, mild impairment 73 74 74 74 
Hearing loss, mild 74 72 71 72 
Higher DW
Lower DW
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‘Infectious disease, acute episode, mild’ and ‘Chronic kidney disease
(stage IV)’ between Hungary and Sweden (Supplementary
Appendix).
Discussion
In this study, we aimed to assess the impact of country, sex, age,
disease or injury experience status, educational and income levels on
the evaluation of infectious disease health states.
First, we found a lower correlation of the probit coefficients
between countries than between the other respondent characteris-
tics. It means that we observed more variation of the health states
valuation between countries than between the other respondent
characteristics. Especially the correlation of the probit coefficient
was lower between Hungary and the Netherlands than between the
other pairs. This translated in some major differences, as for ‘motor
plus cognitive impairments, severe’, that was ranked as the 25th
worse health state in the Netherlands while instead fourth, seventh
and ninth in Hungary, Italy and Sweden. We also observed that the
model including country as covariate had the lowest AIC. This is in
line with the results of the correlation analysis. The observed
variations of health state valuation across country could reflect a
combination of different demographics and/or different attitudes
but also expressed that the included characteristics did not fully
explain the between country differences.
We found a high correlation of the probit coefficients between
educational levels, both across and within countries. This means that
educational levels had no influence on health valuation. In 2008,
Haagsma et al. also demonstrated no significant effects of educa-
tional level on DWs for injury consequences in Dutch population.28
In all countries, we observed a better correlation of the coefficients
between 35–49 years and 50–65 years groups than between the other
age groups. Dolan et al. also demonstrated that age group has an
impact on health valuation.15,16
Within country we observed a lower correlation of the probit
coefficients between income levels, especially between low and
high income levels, except for the Netherlands where the lowest
correlation was found between medium and high income levels.
Our results also showed that the probit coefficients did not vary
widely across disease experience status and sex.
Although this study highlighted the effect of participants’ charac-
teristic on health valuation using a sample of 30 660 answers, it also
had some limitations.
First, we performed a web-based survey and did not include re-
spondents aged 65 years or older. Elderly people are more often
affected by some health states as hearing loss or distance vision
loss, and may suffer of comorbidities.29 However, we did not dem-
onstrate a relationship between DWs and disease experience status.
Therefore this limitation may have had only a limited impact on the
derived DWs.
Second, as in Salomon et al. in 2010, our study elicited DW by
presenting brief health state descriptions in lay language and some
aspects of health states were inevitably omitted in the interest of
brevity. For example, people suffering from chronic irritable bowel
syndrome need to undergo a restrictive diet which is not included in
the health state description and can lead to a higher long-term dis-
ability.30 In addition, there may also have been differences between
languages in the connotation of the words that were used in the
health state descriptions. This could impact health state preferences
of respondents and subsequently increase or decrease the value of
the DW and impact the final ranking of the DWs.
Third, comparisons of DWs derived using a paired comparison
approach across countries and participant characteristics are difficult
and have to be interpreted with caution.31 Due to the nature of the
paired comparison questions, the results hold only relative informa-
tion. It is therefore not possible to compare the mean of all DWs
across countries or between participants’ characteristics and
for instance to conclude if one country has in average a higher or
lower valuation of health. Instead, we explored different approaches
for evaluating relative differences. First, we fitted different probit
regression models to evaluate the interaction effects of country
and participant characteristics. Comparison of models was only
possible based on AIC values, which do not have an absolute inter-
pretation and for which no null hypothesis distribution is available.
AIC values thus do not allow to conclude on statistical significance
of differences between models. Second, we used correlation coeffi-
cients to compare the rankings between different countries or par-
ticipant characteristics. Because of the high number of observations,
all correlation coefficients were significantly different from zero.
Furthermore, the resulting correlation coefficients were all
relatively high (>0.84). However, a definition of what could be
considered sufficiently high depends on context and cannot be
provided by statistical models. Although we observed a high
agreement of the health states valuation for all sub-groups, we still
observed variation of the ranking of DWs between some sub-groups.
This has to be considered because that could have an impact on the
final derived DWs and indirectly on burden of infectious diseases
estimates and policy priorities.
Despite these limitations, we believe that this study brings an
empirical basis for understanding the health state preferences
related to infectious diseases of a diverse set of European respond-
ents. We observed that health state evaluations are highly correlated
across participants’ characteristics but that there exists some
variation in health assessment across country and within country
between income levels. This means that country and income levels
may have an impact on health state valuation. These variations
should be further explored in a systematic way, also in non-
European countries. There is a need of future studies aiming to be
more representative of study populations in future DW elicitation
exercises. We also recommend future researches studying the effect
of other characteristics of respondents on health assessment.
Supplementary data
Supplementary data are available at EURPUB online.
Acknowledgements
The authors are grateful to Piotr Kramarz (European Centre for
Disease Prevention and Control), Wouter Rottier (UMC Utrecht),
Heidi van Ammerlaan (UMC Utrecht), Jolanda van Oirschot (GfK)
and Marcel Temminghoff (GfK) who provided valuable contribu-
tions to this study.
Author contributions
CMdN: study design, data analysis, drafting the manuscript; BD:
data analysis, drafting the manuscript; JS: study design, data
analysis, critically revising the manuscript; HT: data analysis,
critically revising the manuscript; AC: study design, critically
revising the manuscript; EC: study design, critically revising the
manuscript; NS: data analysis, critically revising the manuscript;
SP: study design, critically revising the manuscript; MK: study
design, critically revising the manuscript; AH: study design,
critically revising the manuscript; JH: supervision data-collection,
study design, data analysis, and drafting the manuscript.
Funding
This study was funded by the European Center for Disease
Prevention and Control and the Institute for Health Metrics and
Evaluation. The corresponding author had full access to all study
data, and the analysis, interpretation, and the decision to publish
were solely the responsibility of the authors.
132 European Journal of Public Health
Downloaded from https://academic.oup.com/eurpub/article-abstract/28/1/124/4111224
by Erasmus Universiteit Rotterdam user
on 19 February 2018
Conflicts of interest: A Cassini and E Colzani are staff of the European
Centre for Disease Prevention and Control, which provided partial
financial support of the study, provided assistance with translation
of health lay descriptions in the survey. Juanita A Haagsma is
affiliated with the Institute for Health Metrics and Evaluation,
which also provided part of the funding.
Key points
 Using the answers of more than 30 000 Europeans, we
evaluated if disability weights (DWs) varied by country, age,
sex, disease experience status, income and educational levels.
 We observed that there is some variation in health sates
valuation across countries and within country between
income levels. Country and income levels may have an
impact on health state valuation and on derived DWs.
 There is a need of future studies aiming to be more represen-
tative of study populations in future DW elicitation exercises.
 We also recommend future researches studying the effect of
other characteristics of respondents on health assessment.
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